solifenacin succinate has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hara, H; Imamura, T; Ishizuka, O; Minagawa, T; Ogawa, T; Suzuki, A; Ueno, M | 1 |
Alexandre, L; Audet, A; Behr-Roussel, D; Bernabé, J; Caisey, S; Charon, C; Giuliano, F; Kergoat, M; Oger-Roussel, S | 1 |
2 other study(ies) available for solifenacin succinate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M
Topics: Adrenergic Agonists; Adrenergic beta-3 Receptor Agonists; Animals; Cold-Shock Response; Diabetes Mellitus, Type 2; Female; Muscarinic Antagonists; Quality of Life; Rats; Receptors, Adrenergic; Receptors, Muscarinic; RNA, Messenger; Solifenacin Succinate; Urinary Bladder; Urinary Bladder, Overactive | 2023 |
Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Erectile Dysfunction; Male; Penile Erection; Piperazines; Purines; Quinuclidines; Rats; Rats, Wistar; Sildenafil Citrate; Solifenacin Succinate; Sulfones; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder Diseases; Urination; Urological Agents; Vasodilator Agents | 2014 |